STVN:NYSEStevanato Group S.p.A. Analysis
Data as of 2026-05-27 - not real-time
$17.87
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Stevanato Group (STVN) is trading at $17.87, just above its 20‑day SMA (17.86) but well below the 200‑day SMA (20.07), indicating a neutral longer‑term trend. Momentum metrics are mixed – RSI sits at 59 (still below overbought) while the MACD histogram is negative and the signal line is bearish, and volume has been decreasing, suggesting short‑term pressure. The stock carries a high beta of 1.62 and 30‑day volatility of 35.8%, flagging notable price swings. Fundamentally, the company posted 6.6% revenue growth, a solid operating margin of 14.2%, and a forward EPS of $0.85, yet its current PE of 30.3 exceeds the industry average of 27.4 and the DCF‑derived fair value of $10.35 points to potential overvaluation. Analysts rate the stock as a “buy” with a median target of $25, implying roughly 40% upside, but the balance sheet shows $450 M of debt against $112 M of cash and a debt‑to‑equity ratio of 29.4, raising concerns about dividend sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and decreasing volume signal near‑term weakness
- Price hovering just above support at $15.95
- Recent earnings beat but stock price dipped on the news
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus target of $25 suggests ~40% upside
- Revenue growth of 6.6% and improving forward PE to 21
- Strategic guidance to expand RTU cartridge production in 2027
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular demand for drug‑containment and delivery solutions
- Diversified global customer base across pharma and biotech
- Potential operational leverage from engineering segment and contract manufacturing
Key Metrics & Analysis
Financial Health
Revenue Growth6.60%
Profit Margin11.75%
P/E Ratio30.3
ROE9.59%
ROA5.27%
Debt/Equity29.43
P/B Ratio2.8
Op. Cash Flow$261.7M
Free Cash Flow$-57059124
Industry P/E27.4
Technical Analysis
TrendNeutral
RSI59.1
Support$15.94
Resistance$19.05
MA 20$17.86
MA 50$15.93
MA 200$20.07
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$10.35
Target Price$24.83
Upside/Downside38.97%
GradeOvervalued
TypeBlend
Dividend Yield0.35%
Risk Assessment
Beta1.62
Volatility35.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.